|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4745 SEK | +0.96% |
|
-5.10% | -9.27% |
| Apr. 16 | Mendus AB Announces Board Changes | CI |
| Mar. 27 | Mendus AB Announces Ethics Committee Approval for the AMLM22-CADENCE Trial with Lead Product Vididencel in AML | CI |
On July 31, 2023, Mendus AB (publ), closed the transaction.
| 1st Jan change | Capi. | |
|---|---|---|
| -9.27% | 43.59M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
MENDUS AB 
